quinazolines has been researched along with ganciclovir in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (3.45) | 18.2507 |
| 2000's | 3 (10.34) | 29.6817 |
| 2010's | 14 (48.28) | 24.3611 |
| 2020's | 11 (37.93) | 2.80 |
| Authors | Studies |
|---|---|
| Blaese, RM; Candotti, F; Wildner, O | 1 |
| Angeretti, A; Cavallo, R; Gribaudo, G; Landolfo, S; Lembo, D; Mondo, A; Riera, L | 1 |
| Beatrix, O; Dumortier, J; Lapalus, MG; Lombard-Bohas, C; Scoazec, JY; Villarejo, J; Vochelle, V | 1 |
| Freitag, M; Herget, T; Kupfer, R; Marschall, M; Morbitzer, M; Stamminger, T | 1 |
| Griffiths, P; Lumley, S | 1 |
| Holder, D; Lischka, P; Zhang, D; Zimmermann, H | 1 |
| Badshah, C; Maertens, J; Marty, FM | 1 |
| Humar, A; Kumar, D; L’Huillier, AG | 1 |
| Mori, J; Oshima, K; Tanimoto, T | 1 |
| Gentile, G; Micozzi, A | 1 |
| Frange, P; Leruez-Ville, M | 1 |
| Gagelmann, N; Kröger, N; Ljungman, P; Styczynski, J | 1 |
| Chou, S; Ercolani, RJ; Satterwhite, LE | 1 |
| Meesing, A; Razonable, RR | 1 |
| Arasaratnam, RJ; Chong, PP; Drazner, MH; Garg, S; Peltz, M; Prokesch, BC; Teiber, D | 1 |
| Arif, S; Baker, AW; Cox, G; Grewal, DS; Maziarz, EK; Saullo, JH; Strand, A; Turner, N; Wolfe, CR | 1 |
| Sinkó, J | 1 |
| Andre, P; Asner, SA; Buclin, T; Decosterd, LA; Gengler, C; Jaton-Ogay, K; Mercier, T; Meylan, P; Murray, K; Natterer, J; Opota, O; Pérez Marín, M; Perez, MH; Rizzi, M | 1 |
| Bar-On, S; Haynes, RK; Lantsberg, D; Laskov, I; Oiknine-Djian, E; Panet, A; Wolf, DG | 1 |
| Bittel, P; Dahdal, S; Hirzel, C; Hofmann, E; Manuel, O; Sidler, D; Suter-Riniker, F; Walti, LN | 1 |
| Gruber, J; Ingemi, AI; Khardori, N; McMahon, M; Pearston, AP; Ripley, K; Sutton, S; Wilson, TJ | 1 |
| Müller, TF; Näf, B; Rho, E; Schachter, T; von Moos, S; Wüthrich, RP | 1 |
| Descourouez, JL; Garg, N; Jorgenson, MR; Mandelbrot, DA; Odorico, JS; Parajuli, S; Saddler, CM; Smith, JA | 1 |
| Baldanti, F; Campanini, G; Cassaniti, I; Fratini, A; Girelli, F; Meini, A; Novazzi, F; Palumbo, L; Paolucci, S; Plebani, A; Tebaldi, A | 1 |
| Aaltonen, S; Helanterä, I; Koivuviita, N; Lempinen, M; Ortiz, F | 1 |
| Garg, N; Jorgenson, MR; Kleiboeker, H; Mandelbrot, DA; Odorico, JS; Parajuli, S; Saddler, CM; Smith, JA | 1 |
| Abu-Omar, A; Sester, M | 1 |
| Steininger, C; Weinberger, S | 1 |
| Boivin, G; Goyette, N; Piret, J | 1 |
5 review(s) available for quinazolines and ganciclovir
| Article | Year |
|---|---|
Cytomegalovirus.
Topics: Acetates; Antiviral Agents; Benzimidazoles; Bone Marrow Transplantation; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Disease Transmission, Infectious; Double-Blind Method; Female; Ganciclovir; Humans; Male; Organ Transplantation; Organophosphonates; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; Quinazolines; Randomized Controlled Trials as Topic; Ribonucleosides | 2014 |
Maribavir, brincidofovir and letermovir: Efficacy and safety of new antiviral drugs for treating cytomegalovirus infections.
Topics: Acetates; Antiviral Agents; Benzimidazoles; Cytomegalovirus Infections; Cytosine; Ganciclovir; Humans; Organophosphonates; Quinazolines; Ribonucleosides | 2018 |
Comparative Efficacy and Safety of Different Antiviral Agents for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation: A Systematic Review and Meta-Analysis.
Topics: Acetates; Acyclovir; Allografts; Antiviral Agents; Benzimidazoles; Cytomegalovirus; Cytomegalovirus Infections; Female; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Male; Quinazolines; Ribonucleosides; Risk Factors; Valacyclovir | 2018 |
New Developments in the Management of Cytomegalovirus Infection After Transplantation.
Topics: Acetates; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Immunotherapy; Organ Transplantation; Quinazolines; Valganciclovir | 2018 |
[Current treatment modalities of immunocompromised patients with cytomegalovirus infection. II. Therapeutic options and management strategies].
Topics: Acetates; Acyclovir; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; Quinazolines; Stem Cell Transplantation | 2019 |
24 other study(ies) available for quinazolines and ganciclovir
| Article | Year |
|---|---|
Enzyme prodrug gene therapy: synergistic use of the herpes simplex virus-cellular thymidine kinase/ganciclovir system and thymidylate synthase inhibitors for the treatment of colon cancer.
Topics: Antiviral Agents; Bromodeoxyuridine; Colonic Neoplasms; Combined Modality Therapy; Enzyme Inhibitors; Fluorouracil; Ganciclovir; Genetic Therapy; Humans; Quinazolines; Simplexvirus; Thiophenes; Thymidine Kinase; Thymidylate Synthase; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1999 |
The thymidylate synthase inhibitor ZD1694 potently inhibits murine and human cytomegalovirus replication in quiescent fibroblasts.
Topics: Animals; Antiviral Agents; Cells, Cultured; Cytomegalovirus; DNA, Viral; Fibroblasts; Ganciclovir; Humans; Inhibitory Concentration 50; Mice; Muromegalovirus; Polymerase Chain Reaction; Quinazolines; Thiophenes; Thymidylate Synthase; Virus Replication | 2000 |
[Severe acute cytomegalovirus colitis after administration of irinotecan and raltitrexed chemotherapy].
Topics: Acute Disease; Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Camptothecin; Colitis; Cytomegalovirus Infections; Ganciclovir; Humans; Immunocompromised Host; Irinotecan; Male; Quinazolines; Rectal Neoplasms; Sigmoid Neoplasms; Thiophenes | 2003 |
Novel chemical class of pUL97 protein kinase-specific inhibitors with strong anticytomegaloviral activity.
Topics: Antiviral Agents; Blotting, Western; Cell Line; Cells, Cultured; Cidofovir; Cytomegalovirus; Cytosine; Drug Resistance, Viral; Enzyme Inhibitors; Ganciclovir; Humans; Organophosphonates; Phosphotransferases (Alcohol Group Acceptor); Plasmids; Quinazolines; Viral Plaque Assay; Virus Replication | 2004 |
Impact of glycoprotein B genotype and naturally occurring ORF UL56 polymorphisms upon susceptibility of clinical human cytomegalovirus isolates to letermovir.
Topics: Acetates; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Ganciclovir; Genotype; Humans; Microbial Sensitivity Tests; Mutation; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Quinazolines; Viral Envelope Proteins; Viral Structural Proteins | 2016 |
Letermovir Prophylaxis for Cytomegalovirus.
Topics: Acetates; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Ganciclovir; Humans; Quinazolines | 2018 |
Letermovir Prophylaxis for Cytomegalovirus.
Topics: Acetates; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Ganciclovir; Humans; Quinazolines | 2018 |
Letermovir Prophylaxis for Cytomegalovirus.
Topics: Acetates; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Ganciclovir; Humans; Quinazolines | 2018 |
Letermovir Prophylaxis for Cytomegalovirus.
Topics: Acetates; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Ganciclovir; Humans; Quinazolines | 2018 |
New Locus of Drug Resistance in the Human Cytomegalovirus UL56 Gene Revealed by
Topics: Acetates; Amino Acid Substitution; Antiviral Agents; Cell Line; Cytomegalovirus; Cytomegalovirus Infections; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Endodeoxyribonucleases; Ganciclovir; Humans; Mutation; Quinazolines; Viral Structural Proteins | 2018 |
Letermovir successfully used for secondary prophylaxis in a heart transplant recipient with ganciclovir-resistant cytomegalovirus syndrome (UL97 mutation).
Topics: Acetates; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Ganciclovir; Heart Transplantation; Humans; Male; Middle Aged; Mutation; Phosphotransferases (Alcohol Group Acceptor); Quinazolines; Secondary Prevention; Treatment Outcome | 2018 |
Use of Letermovir as Salvage Therapy for Drug-Resistant Cytomegalovirus Retinitis.
Topics: Acetates; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Retinitis; Drug Resistance, Viral; Ganciclovir; Humans; Organ Transplantation; Quinazolines; Salvage Therapy; Transplant Recipients | 2019 |
Compassionate Use of Letermovir in a 2-Year-Old Immunocompromised Child With Resistant Cytomegalovirus Disease.
Topics: Acetates; Antiviral Agents; Child, Preschool; Compassionate Use Trials; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Dose-Response Relationship, Drug; Drug Monitoring; Extracorporeal Membrane Oxygenation; Fatal Outcome; Female; Ganciclovir; Hepatitis, Viral, Human; Humans; Immunocompromised Host; Opportunistic Infections; Pneumonia, Viral; Polymerase Chain Reaction; Quinazolines; Treatment Failure; Viral Load | 2020 |
Artemisone demonstrates synergistic antiviral activity in combination with approved and experimental drugs active against human cytomegalovirus.
Topics: Acetates; Antiviral Agents; Artemisinins; Benzimidazoles; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Interactions; Drug Synergism; Drugs, Investigational; Female; Ganciclovir; Humans; Organ Culture Techniques; Organophosphonates; Placenta; Pregnancy; Quinazolines; Ribonucleosides | 2019 |
Emergence of letermovir resistance in solid organ transplant recipients with ganciclovir resistant cytomegalovirus infection: A case series and review of the literature.
Topics: Acetates; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Ganciclovir; Humans; Organ Transplantation; Quinazolines; Transplant Recipients | 2021 |
Successful Treatment of UL97 Mutation Ganciclovir-Resistant Cytomegalovirus Viremia in a Renal Transplant Recipient With Letermovir and Adjunct Hyperimmune Cytomegalovirus Immunoglobulin: A Case Report.
Topics: Acetates; Antibodies, Viral; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Ganciclovir; Humans; Immunoglobulins, Intravenous; Kidney Transplantation; Male; Middle Aged; Mutation; Postoperative Complications; Quinazolines; Viral Load; Viremia | 2021 |
Use of letermovir-valganciclovir combination as a step-down treatment after foscarnet for ganciclovir-resistant CMV infection in kidney transplant recipients.
Topics: Acetates; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Kidney Transplantation; Quinazolines; Transplant Recipients; Valganciclovir | 2021 |
The addition of adjunctive letermovir to valganciclovir for refractory cytomegalovirus viremia in kidney transplant recipients.
Topics: Acetates; Adult; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Ganciclovir; Humans; Kidney Transplantation; Quinazolines; Transplant Recipients; Valganciclovir; Viremia | 2021 |
Emergence of Letermovir-resistant HCMV UL56 mutant during rescue treatment in a liver transplant recipient with ganciclovir-resistant infection HCMV: a case report.
Topics: Acetates; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Ganciclovir; Humans; Liver Transplantation; Mutation; Neoplasm Recurrence, Local; Quinazolines | 2021 |
Letermovir treatment for CMV infection in kidney and pancreas transplantation: A valuable option for complicated cases.
Topics: Acetates; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Ganciclovir; Humans; Kidney; Kidney Transplantation; Leukopenia; Pancreas Transplantation; Quinazolines | 2022 |
Letermovir conversion after valganciclovir treatment in cytomegalovirus high-risk abdominal solid organ transplant recipients may promote development of cytomegalovirus-specific cell mediated immunity.
Topics: Acetates; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Ganciclovir; Humans; Immunity, Cellular; Kidney Transplantation; Male; Quinazolines; Transplant Recipients; Valganciclovir | 2022 |
Ways to boost cellular immunity in solid organ transplant recipients - The case of letermovir.
Topics: Acetates; Antiviral Agents; Ganciclovir; Humans; Immunity, Cellular; Organ Transplantation; Quinazolines; Transplant Recipients | 2022 |
Reliable quantification of Cytomegalovirus DNAemia in Letermovir treated patients.
Topics: Acetates; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Deoxyribonucleases; DNA, Viral; Ganciclovir; Humans; Quinazolines | 2022 |
In vitro activity of letermovir against human cytomegalovirus isolates with different drug susceptibility phenotypes.
Topics: Acetates; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Ganciclovir; Humans; Mutation; Phenotype; Quinazolines | 2022 |